电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

VSX2 抗体

The 兔 单克隆 anti-VSX2 antibody (ABIN7271331) specifically detects VSX2 in WB. The antibody is reactive with 人 samples.
产品编号 ABIN7271331
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for VSX2 抗体 (ABIN7271331)

抗原

See all VSX2 抗体
VSX2 (Visual System Homeobox 2 (VSX2))

适用

  • 40
  • 26
  • 22
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

宿主

  • 42
  • 5
  • 1

克隆类型

  • 36
  • 12
单克隆

标记

  • 27
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This VSX2 antibody is un-conjugated

应用范围

  • 48
  • 14
  • 11
  • 4
  • 1
  • 1
  • 1
Western Blotting (WB)
  • 原理

    CHX10 Rabbit mAb

    交叉反应

    人, 小鼠, 大鼠

    产品特性

    Monoclonal Antibodies

    纯化方法

    Affinity purification

    免疫原

    A synthesized peptide derived from human CHX10

    亚型

    IgG
  • 应用备注

    WB,1:500 - 1:2000

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C

    储存方法

    Store at -20°C. Avoid freeze / thaw cycles.
  • 抗原

    VSX2 (Visual System Homeobox 2 (VSX2))

    别名

    VSX2

    背景

    This gene encodes a homeobox protein originally described as a retina-specific transcription factor. Mutations in this gene are associated with microphthalmia, cataracts and iris abnormalities. [provided by RefSeq, Oct 2009],CHX10, HOX10, MCOP2, MCOPCB3, RET1,Epigenetics & Nuclear Signaling,Neuroscience,Transcription Factors,VSX2

    分子量

    50kDa

    基因ID

    338917

    UniProt

    P58304

    途径

    Dopaminergic Neurogenesis
You are here: